ACHILLES EXPRESS ULTRASONOMETER

FDA Premarket Approval P970040 S001

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for a design change that was primarily to replace the open water bath with water enclosed in silicone membranes. The device, as modified, will be marketed under the trade name achilles express and is indicated for: the achilles express ultrasonometer measures ultrasound variables of the os calcis to provide a clinical measure called stiffness index. The stiffness index indicates risk of osteoporotic fracture in postmenopausal women comparable to bone mineral density (bmd) as measured by x-ray absorptiometry at the spine or hip.

DeviceACHILLES EXPRESS ULTRASONOMETER
Generic NameBone Sonometer
ApplicantGE LUNAR CORP.
Date Received1999-02-16
Decision Date1999-04-23
PMAP970040
SupplementS001
Product CodeMUA 
Advisory CommitteeRadiology
Supplement TypeReal-time Process
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address GE LUNAR CORP. 726 Heartland Trail madison, WI 53717

Supplemental Filings

Supplement NumberDateSupplement Type
P970040Original Filing
S003 2004-07-15 Normal 180 Day Track No User Fee
S002 2001-05-07 Normal 180 Day Track
S001 1999-02-16 Real-time Process

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.